D Esrig
Overview
Explore the profile of D Esrig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stein J, Kurzrock E, Freeman J, Esrig D, Ginsberg D, Grossfeld G, et al.
Tech Urol
. 1999 Oct;
5(3):166-8.
PMID: 10527262
We report a case of right intrathoracic renal ectopia associated with a previously unreported congenital anomaly (trisomy 21) and review of the literature.
2.
Bochner B, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols P, et al.
Clin Cancer Res
. 1998 Nov;
3(9):1615-22.
PMID: 9815851
The purpose of this investigation was to evaluate the relationship between tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. We studied 161 patients with invasive transitional cell carcinoma...
3.
Stein J, Grossfeld G, Ginsberg D, Esrig D, Freeman J, Figueroa A, et al.
J Urol
. 1998 Aug;
160(3 Pt 1):645-59.
PMID: 9720515
Purpose: We provide a contemporary review of bladder tumor markers and summarize their role as prognostic indicators. Materials And Methods: A comprehensive review of the literature on prognostic markers for...
4.
Stein J, Ginsberg D, Grossfeld G, Chatterjee S, Esrig D, Dickinson M, et al.
J Natl Cancer Inst
. 1998 Jul;
90(14):1072-9.
PMID: 9672255
Background: Altered expression of p53 protein is an important predictor of progression in bladder cancer. The action of p53 on cell cycle regulation is mediated, in part, through expression of...
5.
Stein J, Esrig D, Freeman J, Grossfeld G, Ginsberg D, Cote R, et al.
Urology
. 1998 Jun;
51(6):951-5.
PMID: 9609632
Objectives: To prospectively evaluate our previously established pathologic risk factors in women undergoing cystectomy for bladder cancer and to determine if these criteria identify appropriate female candidates for orthotopic diversion....
6.
Esrig D, Freeman J, Stein J, SKINNER D
Semin Urol Oncol
. 1997 Aug;
15(3):154-60.
PMID: 9394910
Early radical cystectomy for a high-grade tumor invading the lamina propria (T1) remains controversial. In 1997, we cannot identify accurately which of these high-risk tumors will progress to muscle-invasive disease...
7.
Salem C, Tomasic N, Elmajian D, Esrig D, Nichols P, Taylor C, et al.
J Urol
. 1997 Aug;
158(2):510-4.
PMID: 9224335
Purpose: We determined the extent of p53 immunoreactivity in pathological stage C prostate cancer as well as its correlation to tumor grade, substage, recurrence and proliferation rate. To define better...
8.
Stein J, Grossfeld G, Freeman J, Esrig D, Ginsberg D, Cote R, et al.
J Urol
. 1997 Aug;
158(2):400-5.
PMID: 9224311
Purpose: Orthotopic lower urinary tract reconstruction has revolutionized urinary diversion following cystectomy. Initially performed solely in male patients, orthotopic diversion has now become a viable option in women. Currently, the...
9.
Esrig D, Freeman J, Stein J, Elmajian D, LYTTON B, SKINNER D
Urology
. 1997 May;
49(5):768-71.
PMID: 9145987
Vaginal reconstruction is important in sexually active females undergoing anterior exenteration for malignant disease. We describe a technique for vaginal reconstruction used in two women who underwent radical cystectomy that...
10.
Grossfeld G, Ginsberg D, Stein J, Bochner B, Esrig D, Groshen S, et al.
J Natl Cancer Inst
. 1997 Feb;
89(3):219-27.
PMID: 9017002
Background: Thrombospondin-1 (TSP) is a 430-kd glycoprotein that is an important component of the extracellular matrix and is known to be a potent inhibitor of angiogenesis (i.e., formation of new...